With the new round of funding, it will further invest in customer awareness, hiring, strengthening technology platforms including data science capabilities, clinical research, and product development
MediBuddy has raised USD 125 million in Series C funding from Quadria Capital and Lightrock India along with participation from existing investors Bessemer Venture Partners, India Life Sciences Fund III, Rebright Partners, JAFCO Asia, TEAMFund LP, FinSight Ventures, InnoVen Capital, Stride Ventures, and Alteria Capital.
The platform has successfully catered to the healthcare needs of over 3 crore Indians, leveraging its network of 90,000 doctors, 7,000 hospitals, 3,000 diagnostic centers, and 2,500 pharmacies.
With the new round of funding, it will further invest in customer awareness, hiring, strengthening technology platforms including data science capabilities, clinical research, and product development. Avendus Capital was the exclusive financial advisor to MediBuddy on this transaction.
The digital healthcare platform also launched several other initiatives such as at-home sample pickup of blood tests, RT-PCR tests, COVID Vaccination, tracking availability of hospital beds for COVID patients, a 24×7 COVID helpline number, and mental health counselling.